Across TCGA pan-cancer cohorts, NDUFA5P4 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of NDUFA5P4’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where NDUFA5P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFA5P4 is over-expressed in tumor.
BRCA are the cancer types where NDUFA5P4 tumor–normal differential expression is most reproducible.